Replimune

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$2.68-$17
Market Cap
$251.7M
Shares Short
18M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$3.24

News

See more

Yahoo Finance • 10 hours ago

Investors in Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights – REPL

Yahoo Finance • 15 hours ago

REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Replimune Group, Inc. Investors to Contact the Firm Regarding Class Action Lawsuit

Yahoo Finance • 2 days ago

REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Yahoo Finance • 2 days ago

REPL FINAL DEADLINE ALERT: Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman

About

CEO
Dr. Sushil Patel Ph.D.
Address
500 Unicorn Park Drive, Woburn, MA, United States, 01801
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
479